Congress MLA Priyank Kharge raises concern over approval to Bharat Biotech's Covaxin

Ever since the drug regulator has approved Bharat BioTech's Covaxin along with Serum Institute's Covishield for emergency use authorisation in India, a massive political outcry has begun. Senior Congress leaders like Jairam Ramesh, Anand Sharma, and Shashi Tharoor raised concern over the grant of approval to Bharat BioTech's vaccine which is still in its phase three trials. Now, Congress MLA, Priyank Kharge has also put out a tweet questioning the approval of the vaccine. He says:

"Vaccines are all about efficacy and safety. If there are trust issues about efficacy then it's risky to start trails on the population without scientifically published data of trials showing efficacy. The nationalism of vaccine is going to be dangerous. Science should take precedence". Listen in!